– OTC:WILYY
stock price today
$18.99
+0.68
+3.77%
Financial Health
0
1
2
3
4
5
6
7
8
9
Market closed
Open in 1 day
stock price monthly change
-17.64%
month
stock price quarterly change
-17.64%
quarter
stock price yearly change
-15.55%
year
key metrics
Market Cap | 7.37B |
Enterprise value | N/A |
P/E | N/A |
EV/Sales | N/A |
EV/EBITDA | N/A |
Price/Sales | N/A |
Price/Book | N/A |
PEG ratio | N/A |
EPS | 13.76 |
Revenue | 33.77B |
EBITDA | 4.66B |
Income | 3.07B |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | 0% |
Oper. margin | 0% |
Gross margin | 0% |
EBIT margin | 0% |
EBITDA margin | 13.82% |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freestock price history
stock forecast
financial statements
| Mar 2023 | 5.57B | 628.5M | 11.27% |
|---|---|---|---|
| Jun 2023 | 11.20B | 581M | 5.19% |
| Sep 2023 | 5.64B | 647.5M | 11.47% |
| Dec 2023 | 11.34B | 1.21B | 10.7% |
| 2025 | 24.53B | 3.89B | 15.9% |
|---|
Analysts Price target
Financials & Ratios estimates
| Mar 2023 | 29833000000 | 20.84B | 69.87% |
|---|---|---|---|
| Jun 2023 | 29833000000 | 20.84B | 69.87% |
| Sep 2023 | 30546000000 | 21.20B | 69.43% |
| Dec 2023 | 30546000000 | 21.20B | 69.43% |
| Mar 2023 | 926.5M | -343M | -554M |
|---|---|---|---|
| Jun 2023 | 1.86B | -686M | -1.10B |
| Sep 2023 | 1.20B | -550.5M | -666.5M |
| Dec 2023 | 2.24B | -1.12B | -1.15B |
alternative data
| Aug 2023 | 20,570 |
|---|---|
| Sep 2023 | 21,154 |
| Oct 2023 | 21,154 |
| Nov 2023 | 21,154 |
| Dec 2023 | 21,154 |
| Jan 2024 | 21,154 |
| Feb 2024 | 21,154 |
| Mar 2024 | 21,623 |
| Apr 2024 | 21,623 |
| May 2024 | 21,623 |
| Jun 2024 | 21,623 |
| Jul 2024 | 21,623 |
other data
Tuesday, 26 March 2024 | ||
| Best Momentum Stocks to Buy for March 26th | Zacks Investment Research | |
| New Strong Buy Stocks for March 26th | Zacks Investment Research | |
Tuesday, 19 March 2024 | ||
| New Strong Buy Stocks for March 19th | Zacks Investment Research | |
Monday, 11 March 2024 | ||
| Best Momentum Stocks to Buy for March 11th | Zacks Investment Research | |
| New Strong Buy Stocks for March 11th | Zacks Investment Research | |
Thursday, 7 March 2024 | ||
| Best Momentum Stocks to Buy for March 7th | Zacks Investment Research | |
| New Strong Buy Stocks for March 7th | Zacks Investment Research | |
Monday, 4 March 2024 | ||
| Best Momentum Stocks to Buy for March 4th | Zacks Investment Research | |
| New Strong Buy Stocks for March 4th | Zacks Investment Research | |
Monday, 12 February 2024 | ||
| Best Momentum Stocks to Buy for February 12th | Zacks Investment Research | |
Tuesday, 7 February 2023 | ||
| Demant A/S (WILLF) Q3 2023 Earnings Call Transcript | Seeking Alpha | |
Friday, 3 June 2022 | ||
| The Scandinavian Shopping List In A Time Of Bargains | Seeking Alpha |
-
What's the price of stock today?
One share of stock can currently be purchased for approximately $18.99.
-
When is 's next earnings date?
Unfortunately, 's (WILYY) next earnings date is currently unknown.
-
Does pay dividends?
No, does not pay dividends.
-
How much money does make?
has a market capitalization of 7.37B and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 13.89% to 22.44B US dollars.
-
What is 's stock symbol?
null is traded on the OTC under the ticker symbol "WILYY".
-
What is 's primary industry?
Company operates in the Healthcare sector and Medical Devices industry.
-
How do i buy shares of ?
Shares of can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
How many employees does have?
As Jul 2024, employs 21,623 workers.
-
When went public?
null is publicly traded company for more then 14 years since IPO on 24 Jun 2011.
-
What is 's official website?
The official website for is demant.com.
-
How can i contact ?
can be reached via phone at +45 39 17 73 00.
company profile:
Exchange:
OTC
Full time employees:
20,570
Industry:
Medical Devices
Sector:
Healthcare
Demant A/S operates as a hearing healthcare and audio technology company in Europe, North America, the Pacific, Asia, and internationally. It operates in two segments, Hearing Healthcare and Communications. The Hearing Healthcare segment is involved in the manufacturing, servicing, and sale of hearing aids, and diagnostic products and services. The Communications segment provides headsets for the professional call centers, office markets, and gaming markets under the EPOS brand name. The company was formerly known as William Demant Holding A/S and changed its name to Demant A/S in March 2019. Demant A/S was founded in 1904 and is headquartered in Smørum, Denmark.
Kongebakken 9
Smørum, 2765
Smørum, 2765
:
ISIN: US24803R1095
:
